Pharmatech Equipments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth -2.09%
- Profit Growth 81.79%
- Ebitda 42.27%
- Net Worth 21.92%
- Total Assets 48.78%
About Pharmatech Equipments
Pharmatech Equipments Private Limited (PEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 March 2009 and has a history of 15 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rozin Dsouza, John Dsouza, and Roywin Dsouza serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U29297MH2009PTC191199
- Company No.
191199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2009
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pharmatech Equipments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rozin Dsouza  | Director | 24-Mar-2009 | Current |
| John Dsouza | Director | 24-Mar-2009 | Current |
| Roywin Dsouza | Director | 22-Jun-2017 | Current |
Financial Performance of Pharmatech Equipments.
Pharmatech Equipments Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.09% decrease. The company also saw a substantial improvement in profitability, with a 81.79% increase in profit. The company's net worth Soared by an impressive increase of 21.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmatech Equipments?
In 2023, Pharmatech Equipments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹10.00 M
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2018 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Pharmatech Equipments?
Pharmatech Equipments has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmatech Equipments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmatech Equipments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.